THE TAPE

Huntsman Corporation

$9.30▼ −2.41%
Last close
Relative strength
24RS
of 99, against every stock▲ +11 on the month
Turning up
Turning
−12.6%
six months against Chemicals & Allied Products
52-week range
−42.2%
from the high
$8.00$16.09
Setup
On no screen
No base, flag or squeeze in place tonight. What is and is not there
No report date on the calendar.
Growth FLATProof PENDING
Quarter to Mar 31, revenue +1% on a year ago
Why it is on no screen

HUN is off the screens on 3 checks.

A base has formed21.6 weeks, from 8.00 to 16.09.
Long enough to count21.6 weeks against 3 needed.
Shallow enough50.3% deep against 35% allowed.
Close to its pivot-42.2% from the pivot; listed down to -20%.
Relative strengthRS 24 against 70 needed.

Measured against the base-and-breakout thresholds. The other screens use their own numbers, so a name can miss here and still be a fair-looking chart.

Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
Support and resistance
Support below
$8.85
-4.8% · tested 4× · last 11 sessions ago
Resistance above
$9.87
+6.1% · tested 6× · last 2 sessions ago

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

Huntsman Corporation is not on any of the screens right now. Its relative strength rating is 24, and it sits in Chemicals & Allied Products.

Against its industry
TurningBehind its industry over six months, but ahead over one and three.
One month against its industry
+7.7%
Three months against its industry
+3.9%
Six months against its industry
-12.6%

Read against an equal-weighted index of Chemicals & Allied Products, which is -23.1% against the S&P 500 over six months Not aligned.

Peers
Same theme
No themes — common and fine.
Catalyst roadmap
11
days
Ex-dividend in 11 days
Nov 27, 2026
  1. Ex-dividendconfirmedin 11d
    Ex-dividend date
    Nov 27, 2026
How it moves on earnings

On average 5.6% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$5.7B
+0.7% year on year
Operating margin
-3.3%
gross 12.9%
Net margin
-5.8%
Free cash flow
$135.0M
8.3% of market cap
Price to sales
0.29×
Price to earnings
—
not meaningful on a loss

Twelve months to Mar 31, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules
Key takeaway
Cash flow is the weak point of the quarter.
Revenue
$1.4B
+4.8% QoQ · +0.7% YoY
Gross margin
12.9%
+0.8 pts QoQ
Net income
−$53.0M
Loss
Free cash flow
−$91.0M
Burning · 4q runway

What the numbers say

  • Revenue +0.7% year over year, +4.8% on the quarter
  • Gross margin 12.9%, +0.8 points on the quarter
  • Weak: Net loss $53M, narrower than $96M last quarter
  • Weak: Burning cash: operating cash flow -$53M, free cash flow -$91M, worse than $19M last quarter · 4 quarters of cash at this burn
  • Weak: Growth externally funded: capex $38M against operating cash flow -$53M
  • Net debt $1.69B · cash $369M
Revenue by quarter
Free cash flow
Net income
shares +0.3% in a year · net debt $1.7B

What is not obvious

  • Weak: Stock compensation $9M added back against negative operating cash flow
Final read
Growth: FLAT · Economic proof: PENDING
Key question: What turns the cash flow positive?
The next test is operating profit: net loss $53M, narrower than $96M last quarter.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

Held by 3 of 46 tracked funds at the end of Q3 2026.

Last quarter: 2 trimmed, 1 sold out.

Checking your subscription…

From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.

Flagged by the market sweep
Tightening after a sharp runTape · 2026-11-13
range halved after a +21% thrust, at 9.66
No measurable effect: stocks behave like random ones over the next three sessions (887 cases over 60 nights).
Reported resultsFiling · 2026-11-03
2.02
No measurable effect: stocks behave like random ones over the next three sessions (2,340 cases over 54 nights).
Closed above its 20- and 50-day on heavy volumeTape · 2026-11-03
above 20d & 50d on 1.6x volume at 9.95
Mixed: stocks have outrun random stocks by 0.2% over three sessions, not consistently enough to call (1,668 cases over 60 nights). Against their own sector they have lagged by 0.7%.
GappedTape · 2026-10-31
+7.5%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Moved 5%+ up on earningsTape · 2026-10-31
+7.5% on earnings 2026-10-29
No measurable effect: stocks behave like random ones over the next three sessions (604 cases over 42 nights).
GappedTape · 2026-10-22
+6.0%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Earnings date movedEvent · 2026-10-12
2026-10-29 -> 2026-11-02
No measurable effect: stocks behave like random ones over the next three sessions (2,989 cases over 51 nights).

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

What analysts expect
Strong buy0
Buy2
Hold10
Sell1
Strong sell1

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.

X-ray

No completed base to compare this one with yet.

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Huntsman Corporation (HUN) — The Tape